Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Conference News HFSA 2022

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

Todd Neale

October 04, 2022

Presentation TCT 2022

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

Presenter: Majd Hemam

September 18, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

FDA: Class I Recall of Cobalt and Crome ICDs and CRT-Ds Due to Reduced-Energy Shock

L.A. McKeown

August 19, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Todd Neale

May 02, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Advertisement

December 2022 News Roundup

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

September 2022 News Roundup

FDA: Class I Recall of Cobalt and Crome ICDs and CRT-Ds Due to Reduced-Energy Shock

July 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for May 2022

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

February 2022 News Roundup

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content